The World Mitochondria Society (WMS) is preparing for its annual Targeting Mitochondria 2024 conference, which will focus on innovative strategies to “charge” cells by supplying them with extra mitochondria to enhance cellular function and combat diseases.
New Optimer contract to develop bioanalytical tools for RNA therapy
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, today announces the signing of a new development contract with a